NYU Langone Multiple Sclerosis Comprehensive Care Center

240 East 38th Street
New York, New York 10016

We've found

1 trials

at this facility

Pilot Study to Assess the Efficacy & Safety of H.P. Acthar® Gel in Subjects With Relapsing-remitting Multiple Sclerosis

Status: Enrolling, Phase IV
Updated: 12/31/1969

from

New York, NY

Use our guide to learn which trials are right for you!